Emerging Technology

The Schall Law Firm a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Meta Platforms, Inc. fka Facebook, Inc.  for violations of §§10 and 20 of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 3, 2016 and October 4 ...

The Schall Law Firm a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Meta Platforms, Inc. fka Facebook, Inc. ("Facebook" or "the Company") (NASDAQ: FB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between November 3, 2016 , and October 4 , 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before December 27 , 2021.

If you are a shareholder who suffered a loss, click here to participate .

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com , or by email at brian@schallfirm.com .

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Facebook misled the market regarding its user growth. The Company knew or should have known that duplicate accounts represented a considerable portion of its purported growth and failed to disclose the implications of duplicate accounts on its business and revenue growth. The Company failed to maintain a fair platform for all users, including protecting high-profile users with the "Cross Check/XCheck" system. The Company failed to take effective action against bad actors on its platform such as drug cartels, human traffickers, and violent criminals. Based on these facts, the Company's public statements were false and materially misleading. When the market learned the truth about Facebook, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq. ,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/final-deadline-today-the-schall-law-firm-encourages-investors-in-meta-platforms-inc-fka-facebook-inc-with-losses-of-500-000-to-contact-the-firm-301450901.html

SOURCE The Schall Law Firm

News Provided by PR Newswire via QuoteMedia

FB
dgtl

DGTL Holdings Inc. Builds Strong Portfolio in Digital Media, Martech

NetworkNewsAudio DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) announces the availability of a broadcast titled, "Parabolic Growth Curve in Digital Media, Martech Sector Has Tech SPACS and Small Caps Booming."

To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast

Keep reading... Show less
CSE:LXX

Lexaria Provides Strategic Update from CEO

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces the following strategic update. (This is a shortened version of the full Strategic Update from the CEO. For the full version, please go to www.lexariabioscience.com/news/)

“Lexaria’s brightest days lie in the future, not in the past,” said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. Lexaria achieved many things during 2019 – indeed, management feels that it achieved virtually all that it had set out to accomplish and it was its best year ever from an operational perspective. Market forces caused a retreat in valuations across the sector to the point where Mr. Bunka commented that “It is my own opinion that Lexaria shares are dramatically undervalued – more so today than at any time in our history.”

Keep reading... Show less
CSE:LXX

Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Brian Quigley to its board of directors. Mr. Quigley most recently spent 16 years at Altria Group, with 7 of those years spent as President and Chief Executive Officer for U.S. Smokeless Tobacco and Nu-Mark, Altria’s innovation company, during the time that the existing business relationship between Altria and Lexaria was negotiated.

Mr. Quigley is a 20-year Consumer Packaged Goods veteran of managing complex regulatory environments including for novel and innovative nicotine products, with additional deep experience with operations and marketing. In his time at Altria, Mr. Quigley spearheaded harm reduction strategies and worked to deliver results by creating change in the tobacco business in North America. Mr. Quigley has launched dozens of new products, created consumer-focused innovation strategies, and built businesses and cultures that deliver results.

Keep reading... Show less
CSE:LXX

Lexaria Bioscience Receives Cannabis R&D License from Health Canada

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that its subsidiary, Lexaria CanPharm ULC., has been issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 by Health Canada with a four-year term until August 9, 2023 unless renewed.

Lexaria’s new cannabis R&D license is effective immediately and will allow one of the country’s newest and most advanced formulation laboratories to conduct extensive investigatory work in both THC and CBD delivery using proprietary, optimized formulations and techniques. The laboratory was purpose-built, is permitted at local and federal levels, fully outfitted with equipment required to produce DehydraTECHTM infusions as well as including two different methodologies by which the Company can create nano-sized molecules when deemed beneficial and is currently operational.

Keep reading... Show less
CSE:LXX

Lexaria Bioscience Enters CBD License Agreement with Universal Hemp

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp., to provide Lexaria’s patented DehydraTECHTM technology to Universal Hemp LLC, a B2B manufacturing company of high-performing hemp-derived bulk ingredients to the nutraceutical and consumer packaged goods industries, for utilization into many CBD-based food ingredients to be produced and sold across the USA immediately, and in Canada when regulations permit.

Competitive financial details including royalty rates remain confidential and undisclosed although the companies have agreed to disclose minimum payments over the life of the agreement of US$3,750,000.

Keep reading... Show less

Sierra Wireless Announces Debt Financing for CAD$60 million

Company secures new debt facility with CIBC Innovation Banking and the Business Development of Canada

Sierra Wireless, Inc. (NASDAQ: SWIR) (TSX: SW), a world leading IoT solutions provider, today announced that it has entered into a credit agreement for a new debt financing facility with CIBC Innovation Banking as administrative agent, and CIBC Innovation Banking and the Business Development Bank of Canada (BDC) as lenders. The new debt facility is for CAD$60 million and has a term of four years. The new facility will provide additional liquidity to the company's balance sheet.

Keep reading... Show less

Qualcomm Schedules First Quarter Fiscal 2022 Earnings Release and Conference Call

- Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company's financial results for its first quarter fiscal 2022 on Wednesday, February 2, 2022 after the close of the market on the Company's Investor Relations website, at https:investor.qualcomm.comfinancial-information . The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http:www.sec.gov .

Qualcomm will host a conference call to discuss its first quarter fiscal 2022 results which will be broadcast live on February 2, 2022 , beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/events . An audio replay will be available at https://investor.qualcomm.com/news-events/events and via telephone following the live call for 30 days thereafter. To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international callers may dial (201) 612-7415. Callers should use reservation number 13726028.

Keep reading... Show less

Qualcomm Announces Quarterly Cash Dividend

- Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.68 per common share, payable on March 24, 2022 to stockholders of record at the close of business on March 3, 2022 .

About Qualcomm

Keep reading... Show less
DGTL Holdings Inc. Announces Closing of Financing

DGTL Holdings Inc. Announces Closing of Financing

Total Proceeds of $1,068,000 Satisfies Key Condition in Closing of the Proposed Merger with Engagement Labs

DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) ("DGTL" or the "Company"), is pleased to announce the closing of a second and final tranche (the "Final Tranche") of its previously announced private placement offering of subscription receipts ("Subscription Receipts") and closing of its first tranche (the "First Tranche", together with the Final Tranche, the "Offering") on December 7, 2021. Under the Final Tranche, the Company issued 38 Subscription Receipts at an offering price of $1,000 per Subscription Receipt, for aggregate gross proceeds of $38,000, bringing the total number of Subscription Receipts issued pursuant to the Offering to 1,068 for aggregate total gross proceeds of $1,068,000. The completion of the Offering, satisfied a key condition to closing in the arrangement agreement between the Company and Engagement Labs Inc. (TSXV: EL) ("EL") dated August 11, 2021, as amended (the "Arrangement").

The gross proceeds of the Offering (the "Subscription Receipt Proceeds") are held by Garfinkle Biderman LLP ("Garfinkle"), in its capacity as subscription receipt agent, pursuant to the terms of a subscription receipt agreement entered into between DGTL and Garfinkle. Upon the satisfaction and/or waiver of certain escrow release conditions (the "Escrow Release Conditions") each Subscription Receipt will automatically be converted into a $1,000 principal amount Convertible Debenture (as defined below) and the Subscription Receipt Proceeds will be released. The Escrow Release Conditions shall include, without limitation, the completion of the Arrangement pursuant to a plan of arrangement and the delivery by DGTL of a notice to Garfinkle confirming such condition has been met.

The Convertible Debentures will bear interest at an annual rate of 7.00% payable in arrears in equal installments semi-annually. The Convertible Debentures will mature two years following the satisfaction of the Escrow Release Conditions (the "Maturity Date") as will be further set out in debenture certificates to be issued upon conversion of the Subscription Receipts. The principal amount of the Convertible Debenture will be convertible at the holder's option into common shares of DGTL (the "Conversion Shares") at any time prior to the Maturity Date at a conversion price of $0.30 per Conversion Share. Subject to the approval of the TSX Venture Exchange (the "TSXV"), in lieu of paying any interest accrued and payable in respect of the Convertible Debentures, DGTL may elect to settle such interest in Conversion Shares.

In connection with the Offering, the Company is required to pay finder's fees to eligible finders comprised of an aggregate of $49,000 in cash, and such cash finder's fees form part of the Subscription Receipt Proceeds and will be released to the finders upon satisfaction of the Escrow Release Conditions, and DGTL will issue 81,659 finder's warrants ("Finder's Warrants") upon satisfaction of the Escrow Release Conditions. Each Finder's Warrant entitles the holder thereof to purchase one common share of DGTL at a price of $0.40 for a period of 36 months following the date on which the Escrow Release Conditions are satisfied.

The Subscription Receipts and any underlying securities issued pursuant to the Final Tranche are subject to a statutory hold period of four months and one day from the date hereof.

ARRANGEMENT UPDATE

EL is in the process of preparing a joint information circular with DGTL in connection with their annual general and special meeting of shareholders to be held on February 14, 2022, to approve, among other items, the Arrangement.

ABOUT DGTL

DGTL acquires and accelerates transformative digital media, marketing and advertising software technologies, powered by Artificial Intelligence (AI). DGTL (i.e. Digital Growth Technologies and Licensing) specializes in accelerating commercialized enterprise level SaaS (software-as-a-service) companies in the sectors of content, analytics and distribution, via a blend of unique capitalization structures. DGTL is traded on the TSXV as "DGTL", the OTCQB exchange as "DGTHF", and the Frankfurt Stock Exchange as "A2QB0L". For more information, visit: www.dgtlinc.com.

HASHOFF LLC

As a wholly owned subsidiary of DGTL Holdings Inc., Hashoff LLC owns an enterprise level self-service CaaS (content-as-a-service) platform built on proprietary Artificial Intelligence and Machine Learning (AI-ML) technology. Hashoff empowers global brands by identifying, scoring, optimizing, engaging, managing, and tracking top-ranked digital content publishers for global brand marketing campaigns. Hashoff recently launched version 2.0 compatible for video-based applications (e.g. TikTok) and for conversion of social content to web advertisements via programmatic DSP distribution platforms.

Hashoff's active key customer portfolio includes DraftKings, Beam Suntory, Anheuser Busch-InBev, Dunkin Brands, Currency.com, Syneos Health, American Nurses Federation, Philippines Airlines, and channel partners Veritone, Centro, Wideout AQA, etc. Past clients are Nestle, Post Holdings Keurig-Dr. Pepper, Pizza Hut, Live Nation, The CW, Scribd, Novartis, etc.Learn more at https://dgtlinc.com/technology.[i]

CONTACTS - DGTL

John Belfontaine, Director
Email: IR@dgtlinc.com
Phone: +1 (877) 879-3485

Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to the satisfaction of closing conditions including, without limitation: (i) the ability of DGTL to complete the Escrow Release Conditions and (ii) the completion other closing conditions, including, without limitation, obtaining certain consents and TSXV approvals, the operation and performance of the DGTL and EL businesses in the ordinary course until closing of the Arrangement and compliance by DGTL and EL with various covenants contained in the arrangement agreement. In particular, there can be no assurance that the Arrangement will be completed.

Forward-looking statements are based on certain assumptions regarding DGTL and EL, including expected growth, results of operations, performance, continued approval of DGTL's and EL's activities by the relevant governmental and/or regulatory authorities, including the TSXV, and industry trends. While DGTL considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking statements also necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; income tax and regulatory matters; the ability of DGTL and EL to implement their business strategies; competition; currency and interest rate fluctuations, the inability of DGTL to satisfy the Escrow Release Conditions; the inability of DGTL and EL to obtain the necessary approvals, including TSXV approval; the inability of DGTL and EL to complete the other with various covenants contained in the arrangement agreement; and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. DGTL disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. This news release has been approved by the board of directors of DGTL. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in DGTL's public filings and material change reports that will be filed in respect of the Arrangement which are and will be available on SEDAR.

Keep reading... Show less

The Water Institute at the University of Waterloo and BlackBerry Announce Partnership to Address Global Water-Related Challenges

New Innovation Research Challenge Seeks Proposals for Novel Applications of BlackBerry Technologies to Advance Progress Against UN Sustainable Development Goals

Building on a partnership spanning over three decades, BlackBerry Limited (NYSE: BB; TSX: BB) and the University of Waterloo 's Water Institute one of the world's top water research institutes, today launched a first-of-its-kind innovation research challenge for professors and students.

Keep reading... Show less

BlackBerry and PATEO Announce Strategic Collaboration to Deliver Integrated Digital Cockpit Solution Featuring BlackBerry IVY for the Chinese Market

Leading Chinese OEM to Participate in Pilot Project

BlackBerry Limited (NYSE: BB; TSX: BB) and PATEO a leading Internet of Vehicles (IoV) technology service & product provider in China, today announced a strategic collaboration that will see BlackBerry IVY™ integrated into PATEO's intelligent Digital Cockpit solution to develop data-driven in-vehicle services and drive new business opportunities in the Chinese market.

Keep reading... Show less

Latest Press Releases

Related News

×